Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, DSM-Firmenich AG's average EBITDA Per Share Growth Rate was 101.50% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 37.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of DSM-Firmenich AG was 37.60% per year. The lowest was 37.60% per year. And the median was 37.60% per year.
DSM-Firmenich AG (XSWX:DSFIR) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
DSM-Firmenich AG 5-Year EBITDA Growth Rate Related Terms
XSWX:DSFIR vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, DSM-Firmenich AG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG 5-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's 5-Year EBITDA Growth Rate falls into.
DSM-Firmenich AG 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 0.00% mean?
DSM-Firmenich AG (XSWX:DSFIR) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's 5-Year EBITDA Growth Rate too high?
DSM-Firmenich AG's current 5-Year EBITDA Growth Rate is 0.00%. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's 5-Year EBITDA Growth Rate compare to LIN and SHW?
DSM-Firmenich AG's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF78.44, compared to a current price of CHF87.90 — trading 12.1% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. DSM-Firmenich AG's overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF87.90 is trading 12.1% above its estimated GF Value™ of CHF78.44.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for XSWX:DSFIR:
5-Year EBITDA Growth Rate: 0.00%
GF Value™: CHF78.44 vs. price of CHF87.90 (12.1% above fair value)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score
Get the complete analysis for XSWX:DSFIR
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 
